Alaunos Therapeutics, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
2.49M
on 2026-06-30, from 1.60M on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-10 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
2 of its filings are not read yet.
Warrants
106K
Warrants of every class as tagged in the XBRL facts on 2026-06-30, exercise price $9.63. 10-Q ↗
Cash
0.2 quarters
$124K on 2026-06-30 ÷ $682K a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-09-18 | Public offering incl. 0.39M pre-funded | 767,123 | $1.46 | $1.1M | 424B3 ↗ |
| 2025-06-24 | Private placement | not read | not read | $850K | 8-K ↗ |
| 2025-06-20 | Public offering incl. 0.27M pre-funded | 610,399 | $3.36 | $2.0M | 424B3 ↗ |
| 2025-04-11 | Private placement | not read | not read | $500K | 8-K ↗ |
Also on file: a 1-for-5 reverse split, 2025-07-10 8-K ↗